London calling

Why U.S. biotech Verseon decided to list on London's AIM

European companies have been flocking to NASDAQ to raise cash from U.S. investors. But California's Verseon Corp. (LSE:VSN) decided to swim against the tide all the way to London to ensure it brought in shareholders with a

Read the full 378 word article

How to gain access

Continue reading with a
two-week free trial.